Zurueck zur Suche

Reporte zur Charge 0038B21A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

1Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
CO 1

VAERS 1984009

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 0038B21A

gering
Staat
CO
Alter
-
Geschlecht
M
Eingang
28.12.2021
Impfdatum
31.03.2021
Beginn
10.11.2021
Tage bis Beginn
224,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Biopsy skin Blood thyroid stimulating hormone Colonoscopy Computerised tomogram thorax Expired product administered High density lipoprotein decreased Investigation Physical examination Rectal examination

Symptomtext

expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A, 0038B21A and 0038B21A) for COVID-19 vaccination. The patient's past medical history included Diarrhea and Headache. Previously administered products included for Product used for unknown indication: Vaccine, Influenza (Series 1, 05-NOV-2019 Series 2 and 21-OCT-2021). Past adverse reactions to the above products included No adverse event with Vaccine and Influenza. Concurrent medical conditions included Sclerosis multiple (Calvarium, Facial bones and cervical spine), Amnesia transient, Diverticulitis, Clostridium difficile infection, Diverticulosis, Vitamin D deficiency, Splinter hemorrhages, Hypothyroidism, Plantar fasciitis (bilateral), Venous insufficiency (Chronic), Arthralgia, Chest discomfort, Hyperlipidemia, GERD, Prostate cancer, Lung cancer, Colon cancer, Coronary artery disease and Drug allergy (CEFDINIR (CEFDINIR) (Severe)). Concomitant products included LEVOTHYROXINE SODIUM, VITAMIN D3 (VITAMIN D3 2000 UNIT ORAL CAPSULE), ACETYLSALICYLIC ACID (ASPIRIN LOW) and VANCOMYCIN HCL for an unknown indication. On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 10-Nov-2021, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Biopsy skin: abnormal (abnormal) Screen skin cancer, abnormal. On an unknown date, Blood thyroid stimulating hormone: abnormal (abnormal) Thyroid stimulating hormone, abnormal. On an unknown date, Colonoscopy: abnormal (abnormal) Screen colon cancer, abnormal. On an unknown date, Computerised tomogram thorax: abnormal (abnormal) Screen lung cancer, abnormal. On an unknown date, High density lipoprotein decreased: low (Low) Low. On an unknown date, Investigation: abnormal (abnormal) CAD , abnormal. On an unknown date, Physical examination: abnormal (abnormal) Physical exam routine, abnormal. On an unknown date, Rectal examination: inconclusive (Inconclusive) Screening prostate cancer, abnormal. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medications were reported VANCOMYCIN HCL dosage was reported as one three times a day for one week then one twice a day for one week then one daily for one week then one every other day for 2 weeks then one every 3rd day for 2 weeks Services Due were reported as TD BOOSTER, BP DIASTOLIC, BP SYSTOLIC, HEMOCCULT or SIDMOID

Weitere VAERSDATA-Felder
Praegender Schweregrund
Biopsy skin
Hospital-Tage
-
Labordaten
Test Name: Screen skin cancer; Result Unstructured Data: Screen skin cancer, abnormal; Test Name: Thyroid stimulating hormone; Result Unstructured Data: Thyroid stimulating hormone, abnormal; Test Name: Screen colon cancer; Result Unstructured Data: Screen colon cancer, abnormal; Test Name: Screen lung cancer; Result Unstructured Data: Screen lung cancer, abnormal; Test Name: Low HDL; Result Unstructured Data: Low; Test Name: CAD, Screening; Result Unstructured Data: CAD , abnormal; Test Name: Physical exam, routine; Result Unstructured Data: Physical exam routine, abnormal; Test Name: Screening prostate cancer; Test Result: Inconclusive ; Result Unstructured Data: Screening prostate cancer, abnormal
Aktuelle Erkrankungen
Amnesia transient; Arthralgia; Chest discomfort; Clostridium difficile infection; Colon cancer; Coronary artery disease; Diverticulitis; Diverticulosis; Drug allergy (CEFDINIR (CEFDINIR) (Severe)); GERD; Hyperlipidemia; Hypothyroidism; Lung cancer; Plantar fasciitis (bilateral); Prostate cancer; Sclerosis multiple (Calvarium, Facial bones and cervical spine); Splinter hemorrhages; Venous insufficiency (Chronic); Vitamin D deficiency
Vorgeschichte
Medical History/Concurrent Conditions: Diarrhea; Headache
Andere Medikamente
LEVOTHYROXINE SODIUM; VITAMIN D3 2000 UNIT ORAL CAPSULE; ASPIRIN LOW; VANCOMYCIN HCL
Allergien
-
Vorherige Impfungen
-